Hemab Therapeutics (COAG) vs Alpha Tau Medical (DRTS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Hemab Therapeutics is the larger company by market cap ($1.34 billion vs $1.32 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COAG | DRTS |
|---|---|---|
| Share price | $28.70 | $14.25 |
| Market cap | $1.34B | $1.32B |
| 1-day change | +1.16% | -1.59% |
| YTD return | — | +187.88% |
| 1-year return | — | +245.04% |
| 5-year return | — | +44.08% |
| EPS (TTM) | $-4.38 | $-1.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $55.42 | $15.79 |
| 52-week low | $23.00 | $3.43 |
| Distance from 52-week high | -48.21% | -9.75% |
| Analyst consensus | none | none |
| Avg. price target upside | +113.24% | +24.91% |
| Average volume | 455.19K | 568.24K |
| Shares outstanding | 46.71M | 92.48M |
| Employees | 59 | 121 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Hemab Therapeutics
COAG stock →Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark.
Healthcare · Biotechnology · 59 employees
About Alpha Tau Medical
DRTS stock →Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
Healthcare · Biotechnology · 121 employees
COAG vs DRTS FAQ
Which is bigger, Hemab Therapeutics or Alpha Tau Medical?
Hemab Therapeutics (COAG) is larger, with a market capitalization of $1.34B compared with $1.32B for Alpha Tau Medical (DRTS).
Are Hemab Therapeutics and Alpha Tau Medical in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.